BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 29 filers reported holding BIOLINERX LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $2,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 17,500,000 | $14,875,000 | 2.31% |
DAFNA Capital Management LLC | 980,352 | $828,000 | 0.59% |
Senvest Management, LLC | 7,781,641 | $6,575,000 | 0.52% |
SABBY MANAGEMENT, LLC | 2,949,051 | $2,507,000 | 0.16% |
Benchmark Capital Advisors | 144,000 | $122,000 | 0.10% |
Opaleye Management Inc. | 250,000 | $212,000 | 0.09% |
Cutter & CO Brokerage, Inc. | 31,000 | $26,000 | 0.01% |
NEXT Financial Group, Inc | 41,500 | $35,000,000 | 0.01% |
Orbimed Advisors | 1,038,600 | $878,000 | 0.01% |
Harel Insurance Investments & Financial Services Ltd. | 108,000 | $91,000 | 0.01% |